Treatment of acute lymphocytic leukemia in Down syndrome

References

• Arico, M., Ziino, O., Valsecchi, M. G., Cazzaniga, G., Baronci, C., Messina, C., ... Conter, V. (2008). Acute lymphoblastic leukemia and Down syndrome: Presenting features and treatment outcome in the experience of the Italian Association of Pediatric Hematology and Oncology (AIEOP). Cancer, 113, 515–521.10.1002/cncr.v113:3
   PubMed Web of Science ®Google Scholar
• Bohnstedt, C., Levinsen, M., Rosthøj, S., Zeller, B., Taskinen, M., Hafsteinsdottir, S., ... Schmiegelow, K. (2013). Physicians compliance during maintenance therapy in children with Down syndrome and acute lymphoblastic leukemia. Leukemia, 27, 866–870.10.1038/leu.2012.325
   PubMed Web of Science ®Google Scholar
• Buitenkamp, T. D., Mathôt, R. A., de Haas, V., Pieters, R., & Zwaan, C. M. (2010). Methotrexate-induced side effects are not due to differences in pharmacokinetics in children with Down syndrome and acute lymphoblastic leukemia. Haematologica, 95, 1106–1113.10.3324/haematol.2009.019778
   PubMed Web of Science ®Google Scholar
• Buitenkamp, T. D., Izraeli, S., Zimmermann, M., Forestier, E., Heerema, N. A., van den Heuvel-Eibrink, M. M., ...Zwaan, C. M. (2014). Acute lymphoblastic leukemia in children with Down syndrome: A retrospective analysis from the Ponte di Legno study group. Blood, 123, 70–77.10.1182/blood-2013-06-509463
   PubMed Web of Science ®Google Scholar
• Burgio, G. R., Lanzavecchia, A., Maccario, R., Vitiello, A., Plebani, A., & Ugazio, A. G. (1978). Immunodeficiency in Down’s syndrome: T-lymphocyte subset imbalance in trisomic children. Clinical & Experimental Immunology, 33, 298–301.
   PubMed Web of Science ®Google Scholar
• Carsetti, R., Valentini, D., Marcellini, V., Scarsella, M., Marasco, E., Giustini, F., ... Ugazio, A. G. (2015). Reduced numbers of switched memory B cells with high terminal differentiation potential in Down syndrome. European Journal of Immunology, 45, 903–914.10.1002/eji.201445049
   PubMed Web of Science ®Google Scholar
• Creutzig, U. (2005). AML patients with Down syndrome have a high cure rate with AML-BFM therapy with reduced dose intensity. Leukemia, 19, 1355–1360.10.1038/sj.leu.2403814
   PubMed Web of Science ®Google Scholar
• Dördelmann, M., Schrappe, M., Reiter, A., Zimmermann, M., Graf, N., Schott, G., ... Riehm, H. (1998). Down’s syndrome in childhood acute lymphoblastic leukemia: Clinical characteristics and treatment outcome in four consecutive BFM trials. Berlin-Frankfurt-Münster Group. Leukemia, 12, 645–651.
   PubMed Web of Science ®Google Scholar
• Goto, H., Inukai, T., Inoue, H., Ogawa, C., Fukushima, T., Yabe, M., ... Tsuchida, M. (2011). Acute lymphoblastic leukemia and Down syndrome: The collaborative study of the Tokyo Children’s Cancer Study Group and the Kyushu Yamaguchi Children’s Cancer Study Group. International Journal of Hematology, 93, 192–198.10.1007/s12185-011-0765-3
   PubMed Web of Science ®Google Scholar
• Izraeli, S. (2014). How I treat ALL in Down’s syndrome: Pathobiology and management. Blood, 123, 35–40.10.1182/blood-2013-07-453480
   PubMed Web of Science ®Google Scholar
• James, R., Lightfoot, T., Simpson, J., Moorman, A. V., Roman, E., & Kinsey, S. (2008). Acute leukemia in children with Down’s syndrome: The importance of population based study. Haematologica, 93, 1262–1263.10.3324/haematol.12831
   PubMed Web of Science ®Google Scholar
• Kanda, Y. (2013). Investigation of the freely available easy-to-use software ‘EZR’ for medical statistics. Bone Marrow Transplantation, 48, 452–458.10.1038/bmt.2012.244
   PubMed Web of Science ®Google Scholar
• Kojima, S. (2000). An effective chemotherapeutic regimen for acute myeloid leukemia and myelodysplastic syndrome in children with Down’s syndrome. Leukemia, 14, 786–791.10.1038/sj.leu.2401754
   PubMed Web of Science ®Google Scholar
• Lee, P., Bhansali, R., Izraeli, S., Hijiya, N., & Crispino, J. D. (2016). The biology, pathogenesis and clinical aspects of acute lymphoblastic leukemia in children with Down syndrome. Leukemia, 30, 1816–1823.10.1038/leu.2016.164
   PubMed Web of Science ®Google Scholar
• Lundin, C., Forestier, E., Klarskov Andersen, M., Autio, K., Barbany, G., Cavelier, L., ... Johansson, B. (2014). Clinical and genetic features of pediatric acute lymphoblastic leukemia in Down syndrome in the Nordic countries. Journal of Hematology & Oncology, 7, 32. doi:10.1186/1756-8722-7-32
   PubMed Web of Science ®Google Scholar
• Manabe, A., Ohara, A., Hasegawa, D., Koh, K., Saito, T., Kiyokawa, N., ... Tsuchida, M. (2008). Significance of the complete clearance of peripheral blasts after 7 days of prednisolone treatment in children with acute lymphoblastic leukemia: The Tokyo Children’s Cancer Study Group Study L99-15. Haematologica, 93, 1155–1160.10.3324/haematol.12365
   PubMed Web of Science ®Google Scholar
• Matloub, Y., Bostrom, B. C., Hunger, S. P., Stork, L. C., Angiolillo, A., Sather, H., ... Gaynon, P. S. (2011). Escalating intravenous methotrexate improves event-free survival in children with standard-risk acute lymphoblastic leukemia: A report from the Children’s Oncology Group. Blood, 118, 243–251.10.1182/blood-2010-12-322909
   PubMed Web of Science ®Google Scholar
• Patrick, K., Wade, R., Goulden, N., Rowntree, C., Hough, R., Moorman, A. V., ... Vora, A. (2014). Outcome of Down syndrome associated acute lymphoblastic leukaemia treated on a contemporary protocol. British Journal of Haematology, 165, 552–555.10.1111/bjh.2014.165.issue-4
   PubMed Web of Science ®Google Scholar
• Ram, G., & Chinen, J. (2011). Infections and immunodeficiency in Down syndrome. Clinical & Experimental Immunology, 164, 9–16.10.1111/cei.2011.164.issue-1
   PubMed Web of Science ®Google Scholar
• Ross, J. A. (2005). Epidemiology of leukemia in children with Down syndrome. Pediatric Blood & Cancer, 44, 8–12.10.1002/(ISSN)1545-5017
   PubMed Web of Science ®Google Scholar
• Schmiegelow, K. (2006). How to adapt drug doses in maintenance therapy of ALL. SIOP Education Book, 17–28.
   Google Scholar
• Whitlock, J. A. (2006). Down syndrome and acute lymphoblastic leukaemia. British Journal of Haematology, 135, 595–602.10.1111/bjh.2006.135.issue-5
   PubMed Web of Science ®Google Scholar
• Xavier, A. C., Ge, Y., & Taub, J. W. (2009). Down syndrome and malignancies: A unique clinical relationship. The Journal of Molecular Diagnostics, 11, 371–380.10.2353/jmoldx.2009.080132
   PubMed Web of Science ®Google Scholar
• Zwaan, C. M., Kaspers, G. J., Pieters, R., Hählen, K., Janka-Schaub, G. E., van Zantwijk, C. H., ... Veerman, A. J. (2002). Different drug sensitivity profiles of acute myeloid and lymphoblastic leukemia and normal peripheral blood mononuclear cells in children with and without Down syndrome. Blood, 99, 245–251.10.1182/blood.V99.1.245
   PubMed Web of Science ®Google Scholar